Inventor · disambiguated record
Mark Berger
Also filed as: BERGER MARK · BERGER MARK S
4 granted patents·11 pending applications·6 citations·filing 2004–2024
64Inventor score
Files withACTINIUM PHARMACEUTICALS INC7BERGER MARK S2BULLER RICHARD2KADMON CORP LLC1SMITHKLINE BEECHAM CORK LTD1
Top patents by PatentIndex Score
15 records- 0185US7727968B2Combination therapy for the treatment of acute leukemia and myelodysplastic syndromeWYETH LLC·Filed 2007·Granted Jun 1, 2010·5 cites·20 claims
- 0272US2024408250A1Methods for treatment of patients with myelodysplastic syndromesACTINIUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0371US11912780B2Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapiesACTINIUM PHARMACEUTICALS INC·Filed 2018·Granted Feb 27, 2024·1 cites·25 claims
- 0466US2023381179A1Methods of Treating Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantationKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 0565US12491274B2Radioconjugates targeting CD33 in the treatment of sarcomasACTINIUM PHARMACEUTICALS INC·Filed 2022·Granted Dec 9, 2025·0 cites·2 claims
- 0665US2010069411A1Cancer treatment methodSMITHKLINE BEECHAM CORK LTD·Filed 2007·Application pending·0 cites
- 0764US2024158528A1Anti-cd45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapiesACTINIUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0861US12083192B2Methods for treatment of patients with myelodysplastic syndromesACTINIUM PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2024·0 cites·18 claims
- 0958US2013296261A9Cancer Treatment MethodBULLER RICHARD·Filed 2012·Application pending·0 cites
- 1051US2024299600A1Method for treating acute myeloid leukemia using venetoclax in conjunction with lintuzumab-ac225ACTINIUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1147US2011301185A1Cancer treatment methodBULLER RICHARD·Filed 2011·Application pending·0 cites
- 1242US2004176339A1Antineoplastic combinationsWYETH CORP·Filed 2004·Application pending·0 cites
- 1339US2021179710A1Combination immunotherapy and chemotherapy for the treatment of a hematological malignancyACTINIUM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1430US2010063074A1Cancer Treatment MethodBERGER MARK S·Filed 2005·Application pending·0 cites
- 1528US2009317383A1Cancer treatment methodBERGER MARK S·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Berger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →